5-MeO-DIPT
- Molecular formula
- C16H24N2O
- CAS Number
- 4021-34-5
- IUPAC Name
- 1-(5-methoxy-1H-indol-3-yl)-N-methyl-propan-2-amine
- Molecular Weight
- 246.38g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1000g/cm3
- Synonyms
- 4822-13-3
Identification
Intriguing Insights into 1-(5-Methoxy-1H-Indol-3-yl)-N-methyl-propan-2-amine
1-(5-Methoxy-1H-Indol-3-yl)-N-methyl-propan-2-amine, often referred to as a derivative of tryptamine, belongs to a fascinating class of compounds that exhibit potential psychoactive properties. Here are some noteworthy points about this compound:
- Structural Complexity: The compound features an indole structure, which is prevalent in many natural products, particularly in biological systems, contributing to its potential interactions in the brain.
- Psychopharmacological Interest: Researchers are particularly drawn to this compound due to its structural similarity to well-known psychedelic substances, spurring investigations into its possible effects on mood and cognition.
- Applications in Research: With the resurgence of interest in psychedelics for therapeutic use, compounds like this are being studied for their implications in treating conditions such as depression, anxiety, and PTSD.
- Natural Sources: Compounds related to this structure are often isolated from various plants and fungi, making them a subject of interest in ethnobotany and natural product chemistry.
- Substituents Matter: The presence of the methoxy group in this compound is pivotal, as even small modifications in chemical structure can significantly alter pharmacological activity.
In summary, 1-(5-methoxy-1H-indol-3-yl)-N-methyl-propan-2-amine is more than just a chemical entity; it symbolizes the intricate relationship between chemistry and neuroscience, providing a platform for innovative research into the therapeutic dimensions of psychedelics. As the field of psychopharmacology continues to evolve, compounds like this may unlock new pathways for understanding the human psyche and developing novel treatments.